Research advances in medical treatment of metabolic associated fatty liver disease
DOI:10.3969/j.issn.1001-5256.2021.04.048
- VernacularTitle:代谢相关脂肪性肝病的内科治疗进展
- Author:
Sutong LIU
1
;
Kaiqi SU
;
Chenlu ZHAO
;
Lihui ZHANG
;
Wenxia ZHAO
Author Information
1. The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Zhengzhou 450046, China
- Publication Type:Research Article
- Keywords:
Metabolic Associated Fatty Liver Disease;
Life Style;
Drug Therapy
- From:
Journal of Clinical Hepatology
2021;37(4):947-950
- CountryChina
- Language:Chinese
-
Abstract:
Metabolic associated fatty liver disease (MAFLD) is currently one of the most important liver diseases worldwide, and its incidence rate is increasing year by year. This article summarizes the current research status of medical treatment of MAFLD, including lifestyle changes and individualized drug treatment. Lifestyle changes include diet management, exercise intervention, biological clock adjustment, and psychological intervention, and individualized drug treatment includes insulin sensitizer, vitamin E, weight-loss and lipid-lowering drugs, liver-protecting and transaminase-lowering drugs, and traditional Chinese medicine treatment. At the same time, multidisciplinary treatment is the trend of clinical treatment of MAFLD.
